Twist Bioscience Q3 Earnings Call Highlights
Key Points - Twist Bioscience reported strong fiscal Q3 growth: Revenue rose 23% year over year to $118.4 million, led by DNA Synthesis and Protein Solutions growth of 39% and NGS Applications growth of 12%. The company raised fiscal 2026 revenue guidance to $456 million–$